FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8  |  FHIR Version n/a  User: [n/a]

10968111000001103: Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78591000001111 Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78601000001119 Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
216881000001114 Emselex 7.5mg modified-release tablets (Merus Labs Luxco II S.a R.L.) 28 tablet 2 x 14 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
216891000001111 Emselex 7.5mg modified-release tablets (Merus Labs Luxco II S.a R.L.) 28 tablet 2 x 14 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1504901000001112 Emselex 7.5mg modified-release tablets (Norgine Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1504921000001117 Emselex 7.5mg modified-release tablets (Norgine Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
37402001000001110 Emselex 7.5mg modified-release tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
37402101000001111 Emselex 7.5mg modified-release tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
74099701000001110 Emselex 7.5mg modified-release tablets (Merus Labs Luxco S.a R.L.) 28 tablet 2 x 14 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Is a Darifenacin 7.5mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Is pack of Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has active ingredient Genitourinary smooth muscle relaxant false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has active ingredient Darifenacin false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darifenacin true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Darifenacin hydrobromide true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Darifenacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start